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with DAPT > 12 months were older, more often had history of hy-
pertension, diabetes and chronic kidney disease and were more likely
to have presented with non-ST-elevated myocardial infarction and
left ventricular dysfunction, treated with more drug-eluting stents
(DES) with longer stent length and stent size. In multivariable models,
variation of centers, age (risk ratio [RR] 1.01, 95% conﬁdence interval
[CI] 1.00 to 1.02, p<0.001), history of chronic kidney disease (RR1.73,
95%CI 1.02 to 2.95, p¼0.042) and numbers of DES implantation per
patient (RR1.14, 95%CI1.02 to 1.28, p¼0.021) were independent pre-
dictors of extended DAPT beyond 12 months.
CONCLUSIONS Almost half of patients after stent deployment
continued DAPT beyond 12 months. Prolonged DAPT was associated
with a high incidence of comorbidities and complex intervention as
well as signiﬁcant region variation.
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OBJECTIVES Coronary artery diseases (CAD) is one of the most
common and serious cardiovascular diseases. Studies have shown
that lncRNA closely associated with a number of human diseases,
including CAD. However, the potential functional role of lncRNAs in
CAD remains unclear. We identiﬁed LncRNA-AC100865.1(LncRNA-
CAD) and miR-205-5p. Here, we tested the hypothesis that LncRNA-
CAD and miR-205-5p can participate in the regulation of CAD in vivo
and in vitro.
METHODS A microarray was performed to discovery LncRNA-CAD
and miR-205-5p. Then, a real-time ﬂuorescence quantitative PCR was
used to verify this results. Luciferase reporter was performed to verify
the direct binding site for LncRNA-CAD and miR-205-5p.
RESULTS According to microarray and Q-PCR, compared with con-
trols, LncRNA-CAD and miR-205-5p were signiﬁcantly upregulated in
the plasma of patients with AS. The results from loss and gain func-
tion of LncRNA-CAD indicated that LncRNA-CAD could promote the
expression of miR-205-5p. And PTEN was identiﬁed as a miR-205-5p
target gene to mediate the function of miR-205-5p in AS. By knock-
down the expression of PTEN in HUVECs, it showed enhanced
inﬂammation responses. Further, we investigated the molecular
mechanism by which LncRNA-CAD expression is regulated, Bioinfor-
matics analysis was performed to ﬁnd LncRNA-CAD and miR-205-5p
have potential binding sites and conﬁrmed through luciferase re-
porter, and found that LncRNA-CAD could directly bind to the pro-
moter of miR-205-5p, and regulate the expression of PTEN in the CAD.
CONCLUSIONS Our study reveals a novel CAD regulating model
which is composed of LncRNA-CAD, miR-205-5p and PTEN. Modula-
tion of their levels may provide a new approach for tackling CAD.
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OBJECTIVES Dual antiplatelet therapy (DAPT) cessation increases the
risk of adverse events after percutaneous coronary intervention (PCI).
The present study sought to elucidate the frequency and predictors of
discontinued DAPT (duration shorter than 6 months) after stent
deployment in Chinese population.
METHODS We examined the incidence of discontinued DAPT within 6
months among patients after successful PCI enrolled in a 28-site
Chinese registry. Predictors of prolonged DAPT beyond 12 months
were evaluated using multivariable cox proportional hazards model.
RESULTS Among 3,102 patients, DAPT cessation was in 6.9% (n¼214)
within 6 months after PCI procedure. There was a signiﬁcant hetero-
geneity of DAPT duration among centers. Compared to those without
DAPT discontinuation (duration  6 months), patients with DAPT
discontinued were older, less often had history of hyperlipidemia, and
were more likely to have presented with higher incidence of left
ventricular dysfunction and lower hemoglobin level, underwent
more emergent PCI procedure with increasing number of longerdrug-eluting stents (DES). In multivariable models, variation of cen-
ters, history of dyslipidemia (RR 0.68, 95%CI 0.50 to 0.93, p¼0.014),
hemoglobin level (RR 0.98, 95%CI 0.97 to 0.99, p<0.001) and total
amounts of DES deployment (RR0.64, 95%CI 0.54 to 0.76, p<0.001)
were independent predictors of DAPT cessation< 6 months.
CONCLUSIONS Only less than 7% of patients discontinued DAPT
within 6 months after stent deployment. DAPT cessation was associ-
ated with signiﬁcant region variation, low incidence of comorbidities
and less complex intervention.
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OBJECTIVES We investigated the change of u-PA and its receptor in
different types of the CHD. With the results of coronary artery angi-
ography, we discussed the relationship between the results of coro-
nary artery angiography and the levels of u-PA, u-PAR, to uncover the
clinic role of u-PA, u-PAR in the patients with coronary heart disease.
METHODS We divide all the cases into 4 groups: 30 cases in NCAD
group, 20 patients in SA group, 25 patients in UA group, 30 patients in
AMI group. In all these groups, we measured the expression of u-PAR
on neutrophile with ﬂow cytometry and measured the levels of u-PA
in plasma with a solid phase enzyme-linked immuneosorbent assay
(ELISA) and analysis the relationship between the results of coronary
artery angiography and the levels of u-PA, u-PAR.
RESULTS All the samples taken from the coronary artery in this 4
groups were analyzed. The difference between the expression levels
of u-PAR on neutrophile and the plasma levels of u-PA was signiﬁcant,
the AMI group were higher than the UA group[(69.075.92)%
vs.(51.053.15)%, (0.810.11) mg/L vs. (0.500.05) mg/L, P<0.001];
the UA group were higher than the SA group[(51.053.15% vs.
(30.374.77)%, (0.500.05) mg/L vs. (0.360.04) mg/L,P<0.001]; but
the different between the SA group and the NCAD group was not
signiﬁcant[(30.374.77)% vs. (30.024.65)%, (0.360.04) mg/L vs.
(0.300.03) mg/L, P>0.05]. Compared the samples taken from the
peripheral vessel with the samples taken from the coronary artery, the
difference between the plasma levels of u-PA and the expression
levels of u-PAR on neutrophile was not signiﬁcant (0.0030.002,
P>0.05; -0.120.099, P>0.05). In the samples taken from the coronary
artery, the plasma levels of u-PA and the expression of u-PAR on
neutrophile were all signiﬁcantly related to Jenkins score (r1¼0.943,
P<0.001; r2¼0.814, P<0.001).
CONCLUSIONS We may predict the severity of the pathological
change of the coronary artery through measured the levels of u-PA in
the plasma or the expressions of u-PAR in neutrophile which taken
from the peripheral vessel.
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OBJECTIVES Coronary artery calciﬁcation (CAC) is associated with
greater risk of mortality in elderly individuals. Basic researches have
indicated that bone morphogenetic proteins (BMPs) might activate
coronary artery smooth muscle cell calciﬁcation. However, the pre-
dictive values of serum BMPs for the progression of CAC remain un-
certain. We aimed to assess the values of serum BMP-2, BMP-4 and
BMP-7 for predicting the CAC in the elderly.
METHODS The present study was performed in 573 subjects  65y
undergoing 64 or 320-slice coronary computed tomography angiog-
raphy (CCTA). CAC was evaluated by the Agatston calcium score
determined by CCTA. Serum levels of BMP-2, BMP-4 and BMP-7 were
measured using the appropriate ELISA kits. Correlations between CAC
and BMPs were assessed by Pearson correlation analysis. Multivariate
